Patent Law

Another day in the stent patent wars

By Lawrence B. Ebert, Esq.

Boston Scientific Corporation announced in a press release that the Canadian Federal Court has issued judgment in a lawsuit in which Johnson & Johnson had accused the Company's NIR stent of infringing two Johnson & Johnson Palmaz patents.

The Court dismissed Johnson & Johnson's lawsuit, found that the Company's NIR stent did not infringe one patent of Johnson & Johnson, and found that the other Johnson & Johnson patent was invalid.The trial had taken place earlier this year.

Johnson & Johnson recently filed a second lawsuit in Canada in which the Company's Express and TAXUS Express stents are accused of infringing these same two patents.

"We are very pleased with the decision by the Canadian Federal Court dismissing this case," Boston Scientific Chief Operating Officer Paul LaViolette said.

Full post as published by IPBiz on May 11, 2008 (boomark / email).